Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 28, 2025
Tamm-Horsfall protein biosensors for management of nephrolithiasisWaleed Hassan Almalki, Imran Kazmi, Alzarea Sami I, et al.
Biogerontology|May 5, 2025
ATM and p53 in aging and cancer: a double-edged sword in genomic integritySurya Nath Pandey, Muhammad Afzal, Jyoti Uikey, et al.
Frontiers in Pharmacology|December 12, 2025
CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agentPrasanna Srinivasan Ramalingam, Muhammad Afzal, M Arockia Babu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 2025
Mesothelin in pancreatic cancer: clinical applications and analytical considerationsNeeraj Patel, Aditi Gupta, Riya Mishra, et al.
EXCLI Journal|March 16, 2026
Epigenetic regulation of PANoptosis: DNA methylation, histone modifications and non-coding RNAsYogendra Singh, Muhammad Afzal, M Arockia Babu, et al.
Biogerontology|May 5, 2025
CHIP and aging: a key regulator of proteostasis and cellular senescenceSurya Nath Pandey, Neetu Agrawal, Ehssan Moglad, et al.
Inflammopharmacology|September 10, 2025
Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammationSurya Nath Pandey, M Arockia Babu, Kavita Goyal, et al.
Frontiers in Immunology|December 8, 2025
Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistancePrasanna Srinivasan Ramalingam, Muhammad Afzal, M Arockia Babu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 3, 2025
Thymidine kinase 1 (TK1) as a proteomic biomarker in cancerVijaya Paul Samuel, Muhammad Afzal, M Arockia Babu, et al.
Journal of Drug Targeting|January 23, 2026
The Role of MSC-Derived Exosomes in Immune Modulation and Regenerative MedicineSurya Nath Pandey, Muhammad Afzal, Kavita Goyal, et al.
Pageof 4